Zdrowie i gospodarka · 30/08/2021
FDA Announces Rejection of eCTD Submissions with High-Severity Validation Errors
The FDA's CDER will start rejecting eCTD submissions with validation errors 1551 and 1553, which are considered high-severity errors, starting from an unspecified date. These errors have been added to the eCTD validation criteria specifications.
Source: Federal Register — Food and Drug AdministrationOpen original release →